Poseida Therapeutics, Inc. (NASDAQ:PSTX – Free Report) – Investment analysts at HC Wainwright upped their Q2 2024 EPS estimates for Poseida Therapeutics in a research report issued to clients and investors on Wednesday, May 22nd. HC Wainwright analyst A. He now anticipates that the company will earn ($0.43) per share for the quarter, up from […]
HC Wainwright reaffirmed their buy rating on shares of Poseida Therapeutics (NASDAQ:PSTX – Free Report) in a research note published on Wednesday, Benzinga reports. HC Wainwright currently has a $20.00 target price on the stock. HC Wainwright also issued estimates for Poseida Therapeutics’ Q2 2024 earnings at ($0.43) EPS, Q3 2024 earnings at ($0.46) EPS, […]
Poseida Therapeutics (NASDAQ:PSTX – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research note issued on Wednesday, Benzinga reports. They presently have a $20.00 price target on the stock. Poseida Therapeutics Price Performance Poseida Therapeutics stock opened at $2.97 on Wednesday. Poseida Therapeutics has a one […]
HC Wainwright Reaffirms Buy Rating for Poseida Therapeutics (NASDAQ:PSTX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Poseida Therapeutics (NASDAQ:PSTX) Earns "Buy" Rating from HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.